Garcia-Melendo, C, Morales-Munera, CE, Dalmau, J, Cubiro, X, Lopez-Sanchez, C, Mozos, A, Yelamos, O. Extensive lichen planopilaris as exclusive lichenoid reaction secondary to pembrolizumab in a patient with metastatic melanoma. Dermatologic Therapy. 2022; 35(5)DOI:10.1111/dth.15388. PMID:35174945. IF:3.600(Q1/3D).

Reich, K, Conrad, C, Kristensen, LE, Smith, SD, Puig, L, Rich, P, Sapin, C, Holzkaemper, T, Koppelhus, U, Schuster, C. Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(3)DOI:10.1080/09546634.2021.1892024. PMID:33641593. IF:2.900(Q2/4D).

Iznardo, H, Bredrup, C, Bernal, S, Gladkauskas, T, Mascaro, JM, Roe, E, Baselga, E. Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome. AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2022; 188(4)DOI:10.1002/ajmg.a.62603. PMID:34894066. IF:2.000(Q3/8D).

del Alcazar, E, Lopez-Ferrer, A, Martinez-Domenech, A, Ruiz-Villaverde, R, Llamas-Velasco, MD, Rocamora, V, Julia, M, Notario, J, Fernandez-Freire, LR, Sahuquillo-Torralba, A, Vidal, D, Rivera, R, Carretero, G, Mateu, A, de la Cueva, P, Carrascosa, JM. Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. Dermatologic Therapy. 2022; 35(2)DOI:10.1111/dth.15231. PMID:34820971. IF:3.600(Q1/3D).

Thaci, D, Strober, B, Gordon, KB, Foley, P, Gooderham, M, Morita, A, Papp, KA, Puig, L, Menter, MA, Colombo, MJ, Elbez, Y, Kisa, RM, Ye, JN, Napoli, AA, Wei, L, Banerjee, S, Merola, JF, Gottlieb, AB. Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial. Dermatology and Therapy. 2022; 12(2)DOI:10.1007/s13555-021-00649-y. PMID:35025062. IF:3.400(Q2/3D).

Armstrong, AW, Soliman, AM, Betts, KA, Wang, Y, Gao, YW, Stakias, V, Puig, L. Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. Dermatology and Therapy. 2022; 12(1)DOI:10.1007/s13555-021-00647-0. PMID:34862951. IF:3.400(Q2/3D).

Krueger, J, Puig, L, Thaci, D. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2022; 23(SUPPL 1)DOI:10.1007/s40257-021-00658-9. PMID:35061230. IF:7.300(Q1/1D).

Marrakchi, S, Puig, L. Pathophysiology of Generalized Pustular Psoriasis. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2022; 23(SUPPL 1)DOI:10.1007/s40257-021-00655-y. PMID:35061228. IF:7.300(Q1/1D).

Lebwohl, M, Langley, RG, Paul, C, Puig, L, Reich, K, van de Kerkhof, P, Wu, HL, Richter, S, Jardon, S, Gisondi, P. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey (Oct, 10.1007/s13555-021-00635-4, 2021). Dermatology and Therapy. 2022; 12(1)DOI:10.1007/s13555-021-00656-z. PMID:34989998. IF:3.400(Q2/3D).

Cubiro, X, Garcia-Melendo, C, Tubau-Prims, C, Puig, L. Nodular scabies mimicking breast cancer skin metastasis. Indian Journal of Dermatology Venereology & Leprology. 2022; 88(1)DOI:10.25259/IJDVL_63_2021. PMID:34623049. IF:2.900(Q2/4D).

Mogedas-Vegara, A, Agut-Busquet, E, Marsal, MY, Aguilar, JL, de la Torre, OE. Integra as Firstline Treatment for Scalp Reconstruction in Elderly Patients. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. 2021; 79(12)DOI:10.1016/j.joms.2021.07.009. PMID:34391723. IF:2.136(Q4/8D).

Lopez-Llunell, C, Romani, J, Roe, E, Giavedoni, P, Vidal, D, Wortsman, X. Ultrasonographic patterns of cutaneous sarcoidosis. JOURNAL OF ULTRASOUND IN MEDICINE. 2021; 40(11)DOI:10.1002/jum.15631. PMID:33459396. IF:2.754(Q2/4D).

Amat-Samaranch, V, Agut-Busquet, E, Vilarrasa, E, Puig, L. New perspectives on the treatment of hidradenitis suppurativa. Therapeutic Advances in Chronic Disease. 2021; 12DOI:10.1177/20406223211055920. PMID:34840709. IF:4.970(Q2/3D).

Mercader-Garcia, P, Pastor-Nieto, MA, Gonzalez-Perez, R, Cordoba-Guijarro, S, Gimenez-Arnau, AM, Ruiz-Gonzalez, I, Mora-Fernandez, V, Miquel, J, Silvestre-Salvador, JF, Ortiz-Frutos, FJ, Sanz-Sanchez, T, Rodriguez-Serna, M, Perez-Feal, P, Sanchez-Perez, J, Heras-Mendaza, F, Serra-Baldrich, E, Zaragoza-Ninet, V, Hervella-Garces, M, Gatica-Ortega, ME, Garcia-Doval, I, Descalzo, MA, Borrego, L. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study. CONTACT DERMATITIS. 2021; 85(5)DOI:10.1111/cod.13837. PMID:33745152. IF:6.419(Q1/1D).

Baselga, E, El Hachem, M, Diociaiuti, A, Carnevale, C, Downey, C, Roe, E, Mascaro, P, Neri, I, Leuzzi, M, Bernabeu-Wittel, J, Monserrat-Garcia, MT, Ortiz-Prieto, A, Torrelo, A, Knopfel, N, Vercellino, N, Manunza, F, Oranges, T, Bassi, A, Gonzalez-Ensenat, MA, Vicente, A, Gich, I, Puig, L. Sequelae following infantile haemangiomas treated with propranolol. EUROPEAN JOURNAL OF DERMATOLOGY. 2021; 31(6)DOI:10.1684/ejd.2021.4172. PMID:35107070. IF:2.805(Q2/5D).

Marron, SE, Gomez-Barrera, M, Aragones, LT, Goni-Navarro, A, Vilarrasa-Rull, E, Diaz-Diaz, RM, Garcia-Latasa De Aranibar, FJ, Campos-Rodenas, R, Fuentelsaz-Del Barrio, V, Gilaberte-Calzada, Y, Gracia-Cazana, T, Morales-Callaghan, AM, Ros-Abarca, S, Madrid-Alvarez, MB, Puig, L. Quality of Life in Hidradenitis Suppurativa: Validation of the HSQoL-24. ACTA DERMATO-VENEREOLOGICA. 2021; 101DOI:10.2340/00015555-3905. PMID:34427316. IF:3.875(Q2/3D).

Torres, T, Puig, L, Vender, R, Lynde, C, Piaserico, S, Carrascosa, JM, Gisondi, P, Dauden, E, Conrad, C, Mendes-Bastos, P, Ferreira, P, Leite, L, Lu, JSD, Valerio, J, Bruni, M, Messina, F, Nidegger, A, Llamas-Velasco, M, del Alcazar, E, Mufti, A, White, K, Caldarola, G, Teixeira, L, Romanelli, P, Desai, K, Gkalpakiotis, S, Romanelli, M, Yeung, JN, Nogueira, M, Chiricozzi, A. Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2021; 22(4)DOI:10.1007/s40257-021-00598-4. PMID:33786754. IF:6.233(Q1/2D).

Mahil, SK, Yates, M, Langan, SM, Yiu, ZZN, Tsakok, T, Dand, N, Mason, KJ, McAteer, H, Meynell, F, Coker, B, Vincent, A, Urmston, D, Vesty, A, Kelly, J, Lancelot, C, Moorhead, L, Bachelez, H, Bruce, IN, Capon, F, Contreras, CR, Cope, AP, de la Cruz, C, Di Meglio, P, Gisondi, P, Hyrich, K, Jullien, D, Lambert, J, Marzo-Ortega, H, McInnes, I, Naldi, L, Norton, S, Puig, L, Sengupta, R, Spuls, P, Torres, T, Warren, RB, Waweru, H, Weinman, J, Griffiths, CEM, Barker, JN, Brown, MA, Galloway, JB, Smith, CH, PsoProtect CORE-UK Study Grp. Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(1)DOI:10.1111/bjd.19755. PMID:33368145. IF:11.113(Q1/1D).

Martos-Cabrera, L, Llamas-Velasco, M, Armesto, S, Herrera-Acosta, E, Vidal, D, Vilarrasa, E, Rivera-Diaz, R, de la Cueva, P, Martorell-Calatayud, A, Ballesca, F, Belinchon, I, Carretero, G, Rodriguez, L, Romero-Mate, A, Pujol-Montcusi, J, Salgado-Boquete, L, Sahuquillo-Torralba, A, Coto-Segura, P, Baniandres, O, Feltes, R, Alsina, M, Dauden, E. High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023; 62(3)DOI:10.1111/ijd.16365. PMID:35867958. IF:3.500(Q1/3D).

Muniesa C., Gallardo F., García-Doval I., Estrach M.T., Combalia A., Morillo-Andújar M., De la Cruz-Vicente F., Machan S., Moya-Martínez C., Rovira R., Sanchez-Gonzalez B., Acebo E., Amutio E., Penate, Y, Losada-Castillo, MD, García-Muret M.P., Iznardo H., Román-Curto C., Canueto, J, Fernández-de-Misa R., Flórez Á., Izu R.M., Torres-Navarro I., Zayas A., Pérez-Paredes G., Blanes M., Yanguas J.I., Pérez-Ferriols A., Callejas-Charavia M., Ortiz-Romero P.L., Pérez-Gil A., Prieto-Torres L., González-Barca E., Servitje O.. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(1)DOI:10.1111/jdv.18563. PMID:36017748. IF:8.500(Q1/1D).